source
- Five newly approved drugs achieve strong launches by offering superior efficacy, pricing and accessOver the past year several newly approved therapies have entered the market with sales and uptake that far exceed analyst expectations, driven by strong clinical data, reasonable pricing and easy p…
- Biotech firms must adopt global regulatory strategies to commercialize drugs independentlyBiotech developers are increasingly able to fund the pursuit of regulatory approval and commercial launch on their own, rather than selling their assets early. This new option is driven by a reboun…